Australia, Sept. 30 -- Karuna Therapeutics Inc., owns the trademark (2678487) for 'YUDIGNY' till July 20, 2036.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; antivirals; antibodies for medical purposes; biological preparations for the treatment of cancer; anticoagulants; stem cells for medical purposes; radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes.] and 5 [All items in this class are claimed in the convention application.]
Type of Mark: Word
Date of Acceptance: July 22
Registration Advertised: Sept. 29
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2678487.
Disclaimer: Curated by HT Syndication.
